Connection
Jennifer Diamond to Calcium-Binding Proteins
This is a "connection" page, showing publications Jennifer Diamond has written about Calcium-Binding Proteins.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.144 |
|
|
|
-
Jimeno A, Moore KN, Gordon M, Chugh R, Diamond JR, Aljumaily R, Mendelson D, Kapoun AM, Xu L, Stagg R, Smith DC. A first-in-human phase 1a study of the bispecific anti-DLL4/anti-VEGF antibody navicixizumab (OMP-305B83) in patients with previously treated solid tumors. Invest New Drugs. 2019 06; 37(3):461-472.
Score: 0.144